These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3908123)

  • 1. High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.
    Nielsen J; Karlaganis G; von Hattingberg HM; Schaad UB
    Eur J Clin Pharmacol; 1985; 29(2):225-9. PubMed ID: 3908123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid penetration of moxalactam in ventriculostomy patients.
    Creger RJ; Cowan RI; Nearman HS; Blumer JL; Selman WR; Danziger LH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):839-41. PubMed ID: 4083867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography.
    Diven WF; Obermeyer BD; Wolen RL; Yu VL; Lyon J; Zuravleff J
    Ther Drug Monit; 1981; 3(3):291-5. PubMed ID: 6459665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPLC determination of D and L moxalactam in human serum and urine.
    Ziemniak JA; Chiarmonte DA; Miner DJ; Schentag JJ
    J Pharm Sci; 1982 Apr; 71(4):399-402. PubMed ID: 6211541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience of latamoxef in the field of neurosurgery on the penetration into the cerebrospinal fluid in the patients with postoperative meningitis].
    Miyake S; Tanigawa M; Manabe T; Asano T; Niimi H; Kamata I
    Jpn J Antibiot; 1985 Dec; 38(12):3464-70. PubMed ID: 3834129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxalactam for the treatment of bacterial meningitis in children.
    Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA
    J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of 18 cases of purulent meningitis with moxalactam. Pharmacokinetic data].
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Presse Med; 1983 Jan; 12(3):139-42. PubMed ID: 6220351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis.
    Kaplan SL; Mason EO; Garcia H; Kvernland SJ; Loiselle EM; Anderson DC; Mintz AA; Feigin RD
    J Pediatr; 1981 Jan; 98(1):152-7. PubMed ID: 6450278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative high-performance liquid chromatographic, gas chromatographic, and gas chromatographic-mass spectrometric analysis of ticlopidine in baboon plasma after solid-phase extraction.
    Arnoux P; Sales Y; Mandray M; Lechat P; Berger Y; Cano JP
    J Pharm Sci; 1991 Nov; 80(11):1092-5. PubMed ID: 1815063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.
    Miner DJ; Coleman DL; Shepherd AM; Hardin TC
    Antimicrob Agents Chemother; 1981 Aug; 20(2):252-7. PubMed ID: 6456691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of gram-negative bacillary meningitis with moxalactam.
    Olson DA; Hoeprich PD; Nolan SM; Goldstein E
    Ann Intern Med; 1981 Sep; 95(3):302-5. PubMed ID: 6455950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moxalactam therapy of Haemophilus influenzae type b meningitis in children.
    Chartrand SA; Marks MI; Scribner RK; Johnston JT; Frederick DF
    J Pediatr; 1984 Mar; 104(3):454-9. PubMed ID: 6608581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of moxalactam into the cerebrospinal fluid and its application in therapy of bacterial meningitis.
    Cheng DL; Shi FW; Liu YC; Liu CY
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):634-8. PubMed ID: 3655708
    [No Abstract]   [Full Text] [Related]  

  • 16. Epimerization kinetics of moxalactam in frozen urine and plasma samples.
    Hashimoto N; Ichihashi T; Hirano K; Yamada H
    Pharm Res; 1990 Apr; 7(4):364-9. PubMed ID: 2362909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary disposition of moxalactam.
    Braude AC; Cohen RD; Penner JL; Preston MA; Rebuck AS
    Chest; 1984 Dec; 86(6):881-3. PubMed ID: 6499551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam epimer kinetics in children.
    Nahata MC; Durrell DE; Barson WJ
    Clin Pharmacol Ther; 1982 Apr; 31(4):528-32. PubMed ID: 6460588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of Latamoxef (moxalactam) in cerebrospinal fluid of newborns and premature newborns].
    von Loewenich V; Miething R
    Infection; 1985; 13(2):87-8. PubMed ID: 3997254
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of ceftriaxone in cerebrospinal fluid by ion-pair liquid chromatography.
    de Diego Glaría M; Moscciati GG; Ramos RG
    J AOAC Int; 2005; 88(2):436-9. PubMed ID: 15859068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.